Grey
Network-owned
Address
200 5th Avenue
New York, New York 10010
Web Address
Year Founded
1917
Parent Company
WPP
Web Address
North American Revenue 2021
Full-time Employees 2021
Number of clients 2021
Offices
North America
3
Locations
New York
Cincinnati
Toronto
Executives & Senior Management
Senior Management
Michael Houston Houston
Worldwide CEO
Jason Kahner
President, Global Health & Wellness
Cassandra Sinclair
President, North America Pharma
Tim Jones
Chief Creative Officer/Pharma
Ankit Vahia
hief Strategy Officer/Health & Wellness
Beth Rolfs
Chief Data Officer/Grey New York
Jason Brandt
Executive Global Digital Director, P&G
Amber Guild
CEO, Grey Group New York
Kathleen Sullivan
Chief Financial Officer Of Grey North America
Kelli Tuggle
Chief Operating Officer, Grey NY
Cory Berger
Worldwide Chief Marketing Officer
Agency 100 Book Cover
Capabilities/Services Offered
Professional
Consumer
OTC
Direct Marketing
Med-ed
Med-Tech
Public Health
Data/Analytics
Digital
New Services
Social
Omnichannel
Behavioral Strategy
Medical Communications
New Roles
Roles Added
5
Roles
Kelli Tuggle, Chief Operating Officer, Grey North America
Beth Rolfs, Chief Data Officer, Grey New York
Ankit Vahia, Chief Strategy Officer, Health & Wellness, Grey New York
Tim Jones, Chief creative office, H&W, Grey New York
Caine Fair, Social Lead, Grey H&W
Client Roster
GSK
Pfizer
Lilly
J&J/Janssen
BD
Genentech
Nestle Health Science
Medtronic
Galderma
Ecolab
Sozosei
Astellas
UPMC
Organon
Growth
2021 Growth from Existing Clients
20%
2021 Growth from New Clients
80%
Trends and Challenges
Diversity and inclusion
Talent acquisition/retention
Payer-related challenges
Pricing-related issues
Procurement-related issues
Shrinking pharma budgets
Competition from consultancies and other non-traditional organizations
Healthcare Marketing Trends
More personalization of communications
Need to create more/better content/experiences
Heightened focus on payers
Increased concern over drug pricing
Industry consolidation
Scrutiny around social media
Impact of empowered patients/consumers
Intensified focus on analytics/ROI/measurement
Programs that go “beyond the pill”
Evolution of EHRs
Emphasis on specialty drugs/high-science categories
Adopting a data-science culture
More digital experimentation
Seizing opportunities around cannabis
Working from home
Ongoing fallout from pandemic
Creative Samples